§ Claim under review · Health
"Taking 250 mg of purified Shilajit twice daily for 8 weeks increased the activity of 17 muscle-related gene markers involved in muscle structure, elasticity, repair, and regeneration, according to a study published in the Journal of Medicinal Food (PMID: 27414521)"
Verdict
Mostly accurate
Confidence
HighSummary
The study cited in this ad is real and the post describes it fairly accurately. Researchers gave 16 overweight or obese adults 250 mg of a purified shilajit extract twice daily for 8 weeks, took muscle biopsies, and found 17 extracellular-matrix-related gene readings had increased compared to each person's own starting point, including collagen, elastin, fibrillin, fibronectin, decorin, and myoferlin. What the ad leaves out is important. The study had no placebo group and no control group, only 16 people, and it was partly funded by the company that makes the specific branded extract that was tested, which is not the product being advertised. It also measured only gene activity, not muscle growth, strength, or recovery, so the muscle growth and performance framing goes beyond what was actually tested. Treat this as an early mechanistic signal from a small uncontrolled study, not as proof that shilajit builds or repairs muscle.
The readings
key figures from the evidenceupregulated ECM-related gene probe sets after supplementation
total differentially regulated probe sets after 8 weeks
Why this verdict
Evidence
The cited study is real and the identifiers check out. The study design consisted of a baseline visit, followed by 8 weeks of 250 mg of oral Shilajit supplementation twice daily, and an additional 4 weeks of supplementation with exercise, with blood samples and muscle biopsies collected at each visit.
Microarray analysis identified a cluster of 17 extracellular matrix (ECM)-related probe sets that were significantly upregulated in muscles following 8 weeks of oral supplementation compared with the expression at baseline. This cluster included tenascin XB, decorin, myoferlin, collagen, elastin, fibrillin 1, and fibronectin 1. The authors framed this as evidence that supplementation promoted skeletal muscle adaptation through upregulation of ECM-related genes that control muscle mechanotransduction properties, elasticity, repair, and regeneration . So the post's numbers, dose, duration, gene list, and conclusion language all track the published abstract closely.
Findings
✓ What's accurate 7
- The study exists, PMID 27414521 and PMCID PMC4948208 are correct, and it was published in the Journal of Medicinal Food.
- The dose and duration are accurately stated: 250 mg twice daily for 8 weeks.
- The number 17 is accurate as published, referring to 17 ECM-related probe sets significantly upregulated versus baseline.
- The listed gene families (collagen, elastin, fibrillin, fibronectin, decorin, myoferlin) are accurately reported.
- The descriptors "mechanotransduction, elasticity, repair, and regeneration" are essentially the authors' own wording, not an embellishment.
- The stated conclusion, that shilajit promoted molecular changes associated with skeletal muscle adaptation, matches the paper's conclusion.
- This was human research, not animal or cell-culture work.
≈ What's misleading 6
- Omitted qualifier (study design): the post calls it "a clinical trial" without disclosing that it was open-label and single-arm with no placebo or control group. Changes from baseline in an uncontrolled study cannot be cleanly attributed to the supplement.
- Omitted qualifier (sample size and population): n = 16, all overweight or class I obese adults. The post says "adults," implying general applicability.
- Omitted qualifier (funding and product specificity): the tested material was Natreon's patented, standardized PrimaVie extract, and Natreon partially funded the work. The ad uses this to sell a different company's product. Results from one standardized extract do not automatically transfer to another brand's shilajit.
- Surrogate endpoint presented as outcome: the study measured gene expression, not muscle growth, strength, or recovery. The hashtags "#musclegrowth #recovery #performance" imply functional benefits the 8-week data did not test.
- Precision drift: "17 gene targets" or "17 muscle-related gene markers" is a reasonable shorthand, but the published unit is 17 microarray probe sets out of 175 differentially regulated probe sets. Probe sets are not strictly equivalent to 17 distinct genes.
- Selective presentation: the same 8-week data showed no change in creatine kinase or myoglobin, and the study's exercise component was a separate later phase. The ad presents only the favorable molecular signal.
? What's uncertain 4
- Whether upregulation of these ECM transcripts produces any measurable real-world change in muscle mass, strength, or injury resistance. The study did not test this.
- Whether the finding replicates. Only one small uncontrolled study of this design was found. A separate randomized placebo-controlled trial in 63 recreationally active men reported that 8 weeks of PrimaVie Shilajit at 500 mg per day promoted retention of maximal muscular strength following a fatiguing protocol and decreased baseline hydroxyproline , but that is a different study with different endpoints and does not verify the gene-expression claim.
- How much of the observed change reflects the supplement versus time, diet, seasonal variation, or biopsy-site and batch effects, which an uncontrolled design cannot separate.
- Whether the advertiser's own shilajit product matches the tested extract in fulvic acid content, dibenzo-alpha-pyrone content, or purity. No evidence on that was found.
Sources
5 of 5 linked to recordsDas A, Datta S, Rhea B, Sinha M, Veeraragavan M, Gordillo G, Roy S. "The Human Skeletal Muscle Transcriptome in Response to Oral Shilajit Supplementation." J Med Food. 2016 Jul;19(7):701-709. PMID 27414521, PMCID PMC4948208
ClinicalTrials.gov registration NCT02026414 (trial protocol record)
Nutritional Outlook trade coverage of the study and Natreon's statements
NutraIngredients coverage noting funding source
Keller et al. 2019, J Int Soc Sports Nutr (separate randomized placebo-controlled shilajit strength trial, used here for context)